Atlas Trials

Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy

Clinical trial NCT05285332 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05285332
Sponsor
Changhai Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast NeoplasmsTreatmentMetastatic Breast CancerSurvival
Start date
2022-08-01
Primary completion
2030-12-31
Enrollment
362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.